Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 391Recruiting 209Unknown 93Terminated 92Active not recruiting 77Withdrawn 44Not yet recruiting 36Enrolling by invitation 7Suspended 4No longer available 2Available 1

Sponsor Class

OTHER 4INDUSTRY 2NIH 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Sarcoma 4NET 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Endocrine 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 32Neoplasms 28Colorectal Neoplasms 18Prostatic Neoplasms 17Lung Neoplasms 13Leukemia, Myeloid, Acute 13Glioblastoma 12Stomach Neoplasms 10Head and Neck Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Melanoma 8Glioma 8Brain Neoplasms 8Rectal Neoplasms 7Ovarian Neoplasms 7Neoplasm Metastasis 6Hematologic Neoplasms 6Carcinoma, Hepatocellular 6Uterine Cervical Neoplasms 5Polycystic Ovary Syndrome 5Myelodysplastic Syndromes 5Multiple Myeloma 5Esophageal Neoplasms 5Carcinoma, Renal Cell 5Triple Negative Breast Neoplasms 4Sarcoma 4Lymphoma, B-Cell 4Lymphoma 4

Interventions

tivozanib 1envafolimab 1atezolizumab 1Vaccines 1Nanoparticles 1Health Care Economics and Organizations 1HMPL-013 1Biomarkers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Suspended × OTHER × Sarcoma × Clear all
NCT05264974 2026-05-27

Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization

University of Florida

Phase 1 Suspended
18 enrolled
DermatologicSarcoma

Melanoma, Sarcoma

NCT05941325 2026-05-14

A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma

Shanghai 6th People's Hospital

Phase 2 Suspended
20 enrolled
Sarcoma

Sarcoma

NCT05000294 2026-02-18

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

University of Florida

Phase 1/2 Suspended
29 enrolled
BreastEndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT01921998 2015-02-04

BioACT

The Christie NHS Foundation Trust

Suspended
50 enrolled
LymphoidSarcoma

Lymphoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡